comparemela.com

Latest Breaking News On - Anebulo pharmaceuticals inc - Page 1 : comparemela.com

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Richie-cunningham
Company-or-anebulo
Nasdaq
Securities-exchange
Drug-administration
United-states-department-of-justice
America-poison-centers
Anebulo-pharmaceuticals-inc
Anebulo-pharmaceuticals
Quarter-fiscal-year

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Significant Drop in Short Interest

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Significant Drop in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Anebulo-pharmaceuticals-inc
Anebulo-pharmaceuticals-stock-performance
Anebulo-pharmaceuticals
News-ratings-for-anebulo-pharmaceuticals-daily
Nasdaq
Get-free-report
Anebulo-pharmaceuticals-daily

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Significant Growth in Short Interest

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 4,600 shares, a growth of 39.4% from the February 29th total of 3,300 shares. Based on an average trading volume of 8,700 shares, the short-interest ratio […]

Vanguard-group-inc
Anebulo-pharmaceuticals
Anebulo-pharmaceuticals-inc
Nasdaq
Anebulo-pharmaceuticals-price-performance
News-ratings-for-anebulo-pharmaceuticals-daily
Exchange-commission
Get-free-report
Free-report
Anebulo-pharmaceuticals-daily
Nasdaq-aneb

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Update

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) was the recipient of a large increase in short interest in March. As of March 15th, there was short interest totalling 4,600 shares, an increase of 39.4% from the February 29th total of 3,300 shares. Approximately 0.1% of the shares of the company are sold short. Based […]

Anebulo-pharmaceuticals
Anebulo-pharmaceuticals-inc
Nasdaq
News-ratings-for-anebulo-pharmaceuticals-daily
Anebulo-pharmaceuticals-price-performance
Exchange-commission
Tower-research-capital
Get-free-report
Research-capital
Free-report
Anebulo-pharmaceuticals-daily

LVW Advisors LLC Sells 29,292 Shares of Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB)

LVW Advisors LLC trimmed its stake in shares of Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Free Report) by 4.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 643,039 shares of the company’s stock after selling 29,292 shares during the quarter. LVW Advisors […]

News-ratings-for-anebulo-pharmaceuticals-daily
Anebulo-pharmaceuticals-inc
Anebulo-pharmaceuticals-trading
Exchange-commission
Nasdaq
Lvw-advisors
Anebulo-pharmaceuticals
Vanguard-group-inc
Free-report
Vanguard-group
Get-free-report

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.